With biopharma batch failures averaging every 40 weeks, predictive maintenance and connected monitoring are becoming critical quality levers.
Israel Ortiz
Advertisement
As Vice President and General Manager of Asset Solutions at Accruent, Israel’s primary goal is to ensure the Accruent portfolio of products delivers the highest value to customers. He works alongside his talented team of product managers and solution experts, leveraging innovative processes and strategic market insights to drive success.
Articles by Israel Ortiz
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
The Full Path of Drug Development, and Why So Few Drugs Make It: Q&A with Dr. Ying Huang
4
Moving Beyond the Sample Size Guess: Lessons from 60 Million Clinical Trial Simulations
5